Get the Stockscreener App
22.63
0.79%
-0.18
Tyra Biosciences Inc stock is traded at $22.63, with a volume of 259.24K.
It is down -0.79% in the last 24 hours and up +46.19% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$22.81
Open:
$22.97
24h Volume:
259.24K
Relative Volume:
0.78
Market Cap:
$1.21B
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-14.06
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+5.26%
1M Performance:
+46.19%
6M Performance:
+119.07%
1Y Performance:
+49.18%
1-Day Range:
$22.06
$23.39
1-Week Range:
$21.66
$24.05
52-Week Range:
$6.42
$24.05
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
22.63 | 1.22B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Understanding the Setup: (TYRA) and Scalable Risk - news.stocktradersdaily.com
How Investors Are Reacting To Tyra Biosciences (TYRA) Bolstering Its Regulatory And Oncology Leadership - Sahm
Tyra Biosciences stock hits 52-week high at 22.83 USD By Investing.com - Investing.com Canada
Tyra Biosciences stock hits 52-week high at 22.83 USD - Investing.com
June Brings on Some Huge Insider Buying - AOL.com
Tyra Biosciences (NASDAQ:TYRA) Raised to “Hold” at Wall Street Zen - Defense World
Tyra Biosciences (NASDAQ:TYRA) Raised to "Hold" at Wall Street Zen - MarketBeat
What makes Tyra Biosciences Inc. stock attractive to growth funds2025 Pullback Review & Stock Portfolio Risk Management - Newser
Aug Mood: Why Tyra Biosciences Inc. stock attracts high net worth investorsJuly 2025 Chart Watch & High Win Rate Trade Tips - moha.gov.vn
Can Tyra Biosciences Inc. stock resist market sell offsJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Goldman Sachs initiates coverage of Tyra Biosciences stock with Early-Stage Biotech rating - Investing.com UK
Tyra Biosciences (TYRA): Assessing Valuation After New Leadership Hires to Drive Dabogratinib Pipeline Forward - Sahm
Sio Capital Management LLC Has $7.75 Million Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (TYRA) Stock Analysis Report | Financials & Insights - Benzinga
Should Tyra Biosciences’ (TYRA) Executive Hires Shift the Regulatory Outlook for Its Pipeline? - Sahm
Tyra Biosciences (NASDAQ:TYRA) Shares Gap DownHere's What Happened - MarketBeat
Tyra Biosciences appoints two key executives to leadership team By Investing.com - Investing.com Canada
Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - BioCentury
Tyra Biosciences appoints two key executives to leadership team - Investing.com
Tyra Biosciences Announces Executive Role Changes - TradingView
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer - Eastern Progress
Contrasting Milestone Pharmaceuticals (NASDAQ:MIST) and Tyra Biosciences (NASDAQ:TYRA) - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bull Bear: How Tyra Biosciences Inc. stock reacts to global recession fearsMarket Weekly Review & Weekly Chart Analysis and Guides - moha.gov.vn
Weekly Recap: Why Tyra Biosciences Inc. stock attracts high net worth investorsLong Setup & Fast Exit and Entry Strategy Plans - moha.gov.vn
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighWhat's Next? - MarketBeat
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Director Robert More Sells 246,871 Shares - MarketBeat
Tyra Biosciences (TYRA): Evaluating Valuation Following Phase 2 Milestone in Achondroplasia Pipeline - simplywall.st
Dir More Sells 246,871 ($5M) Of Tyra Biosciences Inc [TYRA] - TradingView
Check Out Tyra Biosciences Inc (TYRA)’s Trade Data Rather Than the Analysts’ Views - Setenews
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Non Muscle Invasive Bladder Cancer Pipeline Insights Report 2025: Emerging Therapies and Key Clinical Advances Reshaping the Future of Treatment - Barchart.com
Best Growth Stocks To Follow Today – November 22nd - Defense World
Insiders Who Sold US$628k Of Tyra Biosciences Made The Right Call - simplywall.st
Why Tyra Biosciences (TYRA) Is Up 34.3% After Launching Phase 2 Trial in Pediatric Achondroplasia - Sahm
Tyra Biosciences stock hits 52-week high at 21.19 USD By Investing.com - Investing.com Nigeria
What Makes Shree Ganesh Bio a Strong Contender in YEARHigh Frequency Trading Trends & Free Exceptional Risk Adjusted Gains - earlytimes.in
Tyra Biosciences stock hits 52-week high at 21.19 USD - Investing.com
There is no doubt that Tyra Biosciences Inc (TYRA) ticks all the boxes. - Setenews
Tyra Biosciences Insider Sold Shares Worth $2,030,923, According to a Recent SEC Filing - MarketScreener
Tyra Biosciences COO Bensen sells $2m in stock By Investing.com - Investing.com India
Is Tyra Biosciences Inc. stock supported by strong fundamentalsJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Insider Sell: Daniel Bensen Sells 125,589 Shares of Tyra Bioscie - GuruFocus
Risk vs reward if holding onto Tyra Biosciences Inc.Weekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should I hold or sell Tyra Biosciences Inc. stock in 2025Trade Volume Summary & Daily Stock Trend Watchlist - newser.com
Is Tyra Biosciences Inc. forming a reversal patternMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Has Tyra Biosciences Inc. found a price floorJobs Report & Momentum Based Trading Signals - newser.com
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tyra Biosciences Inc Stock (TYRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MORE ROBERT J | Director |
Nov 21 '25 |
Sale |
20.25 |
246,871 |
5,000,026 |
3,833,425 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):